SHORT-TERM OUTCOMES OF SURGICAL TREATMENT OF PANCREATIC NEUROENDOCRINE TUMORS ASSOCIATED WITH THE SYNDROME OF MULTIPLEENDOCRINE NEOPLASIA TYPE 1


如何引用文章

全文:

详细

Background: pancreaticneuroendocrine tumors occur in almost all patients with multiple endocrine neoplasia type 1 (MEN1) and are a major cause of death. Surgical resection is the only potentially curative therapy for pNETs, otherwise various endocrine syndromesdevelop threatening the patient's life. Aim: to evaluate the short-term results of surgical management of patients with pancreatic neuroendocrine tumors with MEN1. Materials and methods: by last 20 years, 40 patients with pancreatic neuroendocrine tumors within MEN1 were operated. Results: in the early postoperative period,according to the classification of Clavien-Dindo, complications occurred in 12 (26%) patients. The following types of complications were diagnosed: IIIa in 6 patients; IIIb - in 2; type V in 4 patients. Complications of types I, II and IV were not identified. Conclusion: less percentage of postoperative complications is achieved by performing organ-preserving operations, after precise imaging diagnose, due to minimal intraoperative pancreatic injury.

作者简介

A Egorov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

119991Trubetskaya str., 8, p. 2, Moscow, Russia

I Vasilyev

I.M. Sechenov First Moscow State Medical University (Sechenov University)

119991Trubetskaya str., 8, p. 2, Moscow, Russia

I Ivashov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

119991Trubetskaya str., 8, p. 2, Moscow, Russia

A Thakur

I.M. Sechenov First Moscow State Medical University (Sechenov University)

119991Trubetskaya str., 8, p. 2, Moscow, Russia

参考

  1. Crippa S., Zerbi A., Boninsegna L. et al. Surgical Management of Insulinomas: Short- and Long-term Outcomes After Enucleations and Pancreatic Resections. //Arch. Surg. - 2012. - Vol.147, №3. -P. 261-266.
  2. Calender, A.; Cadiot, G.; Mignon M. Multiple endocrine neoplasia type 1: Genetic and clinical aspects. Gastroenterol. Clin. Biol. 2001, 25, 38-48.
  3. Chanson, P.; Cadiot, G.; Murat, A. Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN 1. GENEM 1. Grouped’Etude des NéoplasiesEndocriniennes Multiples de type 1. Horm. Res. 1997, 47, 211-220.
  4. Franko J, Feng W, Yip L, Genovese E and Moser AJ: Non-functional neuroendocrine carcinoma of the pancreas: Incidence, tumor biology, and outcomes in 2,158 patients. J GastrointestSurg 14: 541-548, 2010.
  5. Niina Y, Fujimori N, Nakamura T, et al. The current strategy for managing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1. Gut Liver 2012;6:287-94.
  6. Егоров А.В., Мусаев Г.Х., Кондрашин С.А. и соавт. Диагностика и лечениебольныхнейроэндокриннымиопухолямиподжелудочнойжелезыприсиндромемножественнойэндокриннойнеоплазии 1го типа // Анналыхирургическойгепатологии. - 2010. - Т.15, №3. -С. 25-30.
  7. Kimura W., Tezuka K., Hirai I. Surgical management of pancreatic neuroendocrine tumors. // Surg. Today. - 2011. - Vol.41, №10. -P. 1332-1343.

版权所有 © Egorov A.V., Vasilyev I.A., Ivashov I.V., Thakur A.S., 2019

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。

##common.cookie##